CORDIS
EU research results

CORDIS

English EN
UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION

UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION

Objective

Bacterial endospores are the most resistant life-forms on earth and the most important single feature of the genus Clostridium. Thus, whilst the pathogenesis of its notorious pathogens (C. botulinum, C. perfringens and C. difficile) is ascribed to the devastating toxins produced (neurotoxins, endotoxins and cytotoxins), it is their capacity to produce spores that lies at the heart of the diseases they cause. This is because spores play the pivotal role in the spread of infection (eg, C. difficile) and in foodstuff contamination and food poisoning (eg, C. botulinum and C. perfringens). The processes of spore formation (sporulation) and germination (return of the dormant spore to toxin-producing, vegetative cells), therefore, represent key intervention points. On the other hand, the majority of clostridia are entirely benign and can sustainably produce all manner of useful chemicals and fuels. Crucially, the regulation of chemical production is intimately linked to that of sporulation. Spores of benign species may also be used as a delivery system for treating cancer. Yet, despite the spore’s importance, little is known of the developmental processes of sporulation and germination. This is because research and training efforts on Clostridium spores are fragmented and there is no coherence between researchers working on pathogenic and industrially important species. CLOSPORE will address this deficiency by pooling the resources of Europe’s leading universities, research organisations and companies, to create an intersectorial Research and Training Programme that is multi-facetted, interdisciplinary and focused on clostridial spores. Accordingly, CLOSPORE will produce the innovative, applied research leaders of the future, able to tackle the big societal challenges facing Europe and the world.

Coordinator

THE UNIVERSITY OF NOTTINGHAM

Address

University Park
Ng7 2rd Nottingham

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 819 863,64

Participants (8)

Sort alphabetically

Sort by EU Contribution

Expand all

HELSINGIN YLIOPISTO

Finland

EU Contribution

€ 538 290,72

NIZO FOOD RESEARCH BV

Netherlands

EU Contribution

€ 510 748,56

UNIVERSIDADE NOVA DE LISBOA

Portugal

EU Contribution

€ 476 712,72

INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA - UNIVERSIDADE NOVA DE LISBOA

Portugal

PURAC BIOCHEM BV

Netherlands

EU Contribution

€ 510 748,56

INSTITUT PASTEUR

France

EU Contribution

€ 525 751,20

Green Biologics Ltd.

United Kingdom

EU Contribution

€ 273 287,88

STICHTING WAGENINGEN RESEARCH

Netherlands

EU Contribution

€ 255 374,28

Partners (9)

Sort alphabetically

Expand all

ASTELLAS PHARMA EUROPE LTD

LANZATECH UK LTD

METABOLIC EXPLORER SA

BIOMERIEUX SA

Ipsen Pharmaceuticals

Atria Finland Ltd

Saarioinen

Snellmanin Lihanjalostus Oy

HKScan Ltd

Project information

Grant agreement ID: 642068

Status

Closed project

  • Start date

    1 January 2015

  • End date

    31 December 2018

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 3 910 777,56

  • EU contribution

    € 3 910 777,56

Coordinated by:

THE UNIVERSITY OF NOTTINGHAM

United Kingdom